QUT professor honored with prestigious award

October 21, 2016

A QUT professor has become the first Australian since Professor Ian Frazer to receive the prestigious West Lake Friendship award.

Professor Matt Brown, QUT Director of Genomics in the Institute of Health and Biomedical Innovation (IHBI), received the award in recognition of his work with the Wenzhou Medical University's (WMU) 1st Affiliated Hospital, in the Chinese city Wenzhou.

As well as building academic ties between Queensland and Wenzhou, Professor Brown established cancer genomics services and research programs at the hospital, bringing personalised medicine to Wenzhou cancer patients to improve treatments and lift survival rates.

The award is given annually to overseas experts who have contributed to the economic and social development of Zhejiang Province in any field.

Professor Brown was presented the award by the Governor of Zhejiang, a province of 54 million people.

"I am honoured to follow in the footsteps of major international names including Professor Ian Frazer in receiving this award," Professor Brown said.

"It reflects the hard work of many people in Brisbane and Wenzhou in building bridges between the two cities.

"The award comes to me but I am very grateful for the support I have received particularly from WMU, its 1st Affiliated Hospital, and QUT."

Over the past five years Professor Brown has organised student and staff exchanges and built research collaborations between WMU and universities in Brisbane.

He is also scientific director at the Centre for Personalised Medicine of WMU's 1st Affiliated Hospital, to be opened in December.

"I hope to strengthen ties between WMU and QUT in particular, with more staff and student exchanges," Professor Brown said.

"WMU has 14,000 medical students who are of very high standard, and both institutions will benefit from undergraduate and PhD student exchange."

Based at the Translational Research Institute and Princess Alexandra Hospital, Professor Brown leads a personalised medicine centre for cancer patients, a partnership between QUT and the Queensland Government's Metro South Health (a region that includes the Princess Alexandra Hospital, Greenslopes Hospital and Logan Hospital).

"By tailoring medical treatments to a patient's genetic profile we ultimately hope to provide more effective chemotherapy and cancer management," Professor Brown said.

"This is a new frontier for medicine that can significantly help people so I'm delighted my work in this field has been recognised internationally."
-end-


Queensland University of Technology

Related Cancer Patients Articles from Brightsurf:

Higher risk of death in cancer patients with COVID-19 may be due to advanced age and more pre-existing conditions, rather than cancer itself
New research presented at this this week's ESCMID Conference on Coronavirus Diseases (ECCVID, online 23-25 September) suggests that the poor outcomes and higher death rates in cancer patients with COVID-19 could be due to them generally being older and having more underlying conditions, rather than due to the cancer itself.

The Lancet: Prostate cancer study finds molecular imaging could transform management of patients with aggressive cancer
Results from a randomised controlled trial involving 300 prostate cancer patients find that a molecular imaging technique is more accurate than conventional medical imaging and recommends the scans be introduced into routine clinical practice.

The art of cancer caregiving: How art therapies benefits those caring for cancer patients
A recent Drexel University study showed coloring and open-studio art therapy benefits stressed caregivers of cancer patients.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer tissue-freezing approach may help more breast cancer patients in lower income countries
A new reusable device created by the Johns Hopkins University can help women with breast cancer in lower income countries by using carbon dioxide, a widely available and affordable gas, to power a cancer tissue-freezing probe instead of industry-standard argon.

Lots of patients with cancer, cancer survivors use but don't report complementary/alternative medicine therapies
This study used data from a nationwide survey to estimate how many patients with cancer and cancer survivors use complementary and alternative medicines (CAMS) in addition to or instead of conventional therapies, and how many don't disclose that to their physicians.

Colorectal cancer in patients with early onset is distinct from that in older patients
New research indicates that colorectal cancer diagnosed at an early age has clinical and genetic features that are different from those seen in traditional colorectal cancer diagnosed later in life.

Comparable risk of recurrent venous thromboembolism between patients with unprovoked venous thromboembolism and patients with cancer
Patients with venous thromboembolism (VTE) carry a high risk of recurrence.

Personalized cancer vaccine may increase long-term survival in patients with deadly brain cancer
An international Phase III study led by researchers at UCLA has found that a personalized GBM vaccine may increase long-term survival in some patients.

Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation
A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.

Read More: Cancer Patients News and Cancer Patients Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.